Report Detail
Global (United States, European Union and China) Dermatophytic Onychomycosis Market Research Report 2019-2025
- RnM3715286 |
- 02 September, 2019 |
- Global |
- 142 Pages |
- QYResearch |
- Pharma & Healthcare
Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
The global dermatophytic onychomycosis market is intensely competitive owing to the presence of numerous small and large vendors that operate at a local or global scale. To survive and succeed in this market, the vendors enter into strategic alliances with smaller players to manufacture and market new drugs.
The Americas dominated this market and is envisaged to retain its dominating market position by the end of 2020 owing to the presence of a well-developed healthcare system
In 2019, the market size of Dermatophytic Onychomycosis is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatophytic Onychomycosis.
This report studies the global market size of Dermatophytic Onychomycosis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dermatophytic Onychomycosis sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Anacor Pharmaceuticals
Galderma
Janssen Biotech
Novartis
Valeant Pharmaceuticals
Abeona Therapeutics
Allergan
Elorac
GlaxoSmithKline
Hexima
Hisamitsu Pharmaceutical
Mayne Pharma
MediQuest Therapeutics
Meiji Seika Pharma
Merz Pharma
Moberg Pharma
NanoBio
NovaBiotics
Nuvo Research
Pfizer
Polichem
Promius Pharma
Sanofi
Seren Pharmaceuticals
Taro Pharmaceutical
Topica Pharmaceuticals
Viamet Pharmaceuticals
Market Segment by Product Type
Oral
Topical
Market Segment by Application
Hospitals
Clinics and laboratories
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Dermatophytic Onychomycosis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dermatophytic Onychomycosis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Dermatophytic Onychomycosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Oral
- 1.3.3 Topical
- 1.4 Market Segment by Application
- 1.4.1 Global Dermatophytic Onychomycosis Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics and laboratories
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Dermatophytic Onychomycosis Market Size
- 2.1.1 Global Dermatophytic Onychomycosis Revenue 2014-2025
- 2.1.2 Global Dermatophytic Onychomycosis Sales 2014-2025
- 2.2 Dermatophytic Onychomycosis Growth Rate by Regions
- 2.2.1 Global Dermatophytic Onychomycosis Sales by Regions 2014-2019
- 2.2.2 Global Dermatophytic Onychomycosis Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Dermatophytic Onychomycosis Sales by Manufacturers
- 3.1.1 Dermatophytic Onychomycosis Sales by Manufacturers 2014-2019
- 3.1.2 Dermatophytic Onychomycosis Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Dermatophytic Onychomycosis Revenue by Manufacturers (2014-2019)
- 3.2.2 Dermatophytic Onychomycosis Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Dermatophytic Onychomycosis Market Concentration Ratio (CR5 and HHI)
- 3.3 Dermatophytic Onychomycosis Price by Manufacturers
- 3.4 Key Manufacturers Dermatophytic Onychomycosis Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Dermatophytic Onychomycosis Market
- 3.6 Key Manufacturers Dermatophytic Onychomycosis Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Oral Sales and Revenue (2014-2019)
- 4.1.2 Topical Sales and Revenue (2014-2019)
- 4.2 Global Dermatophytic Onychomycosis Sales Market Share by Type
- 4.3 Global Dermatophytic Onychomycosis Revenue Market Share by Type
- 4.4 Dermatophytic Onychomycosis Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Dermatophytic Onychomycosis Sales by Application
6 United States
- 6.1 United States Dermatophytic Onychomycosis Breakdown Data by Company
- 6.2 United States Dermatophytic Onychomycosis Breakdown Data by Type
- 6.3 United States Dermatophytic Onychomycosis Breakdown Data by Application
7 European Union
- 7.1 European Union Dermatophytic Onychomycosis Breakdown Data by Company
- 7.2 European Union Dermatophytic Onychomycosis Breakdown Data by Type
- 7.3 European Union Dermatophytic Onychomycosis Breakdown Data by Application
8 China
- 8.1 China Dermatophytic Onychomycosis Breakdown Data by Company
- 8.2 China Dermatophytic Onychomycosis Breakdown Data by Type
- 8.3 China Dermatophytic Onychomycosis Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Dermatophytic Onychomycosis Breakdown Data by Company
- 9.2 Rest of World Dermatophytic Onychomycosis Breakdown Data by Type
- 9.3 Rest of World Dermatophytic Onychomycosis Breakdown Data by Application
- 9.4 Rest of World Dermatophytic Onychomycosis Breakdown Data by Countries
- 9.4.1 Rest of World Dermatophytic Onychomycosis Sales by Countries
- 9.4.2 Rest of World Dermatophytic Onychomycosis Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Anacor Pharmaceuticals
- 10.1.1 Anacor Pharmaceuticals Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.1.4 Dermatophytic Onychomycosis Product Introduction
- 10.1.5 Anacor Pharmaceuticals Recent Development
- 10.2 Galderma
- 10.2.1 Galderma Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.2.4 Dermatophytic Onychomycosis Product Introduction
- 10.2.5 Galderma Recent Development
- 10.3 Janssen Biotech
- 10.3.1 Janssen Biotech Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.3.4 Dermatophytic Onychomycosis Product Introduction
- 10.3.5 Janssen Biotech Recent Development
- 10.4 Novartis
- 10.4.1 Novartis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.4.4 Dermatophytic Onychomycosis Product Introduction
- 10.4.5 Novartis Recent Development
- 10.5 Valeant Pharmaceuticals
- 10.5.1 Valeant Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.5.4 Dermatophytic Onychomycosis Product Introduction
- 10.5.5 Valeant Pharmaceuticals Recent Development
- 10.6 Abeona Therapeutics
- 10.6.1 Abeona Therapeutics Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.6.4 Dermatophytic Onychomycosis Product Introduction
- 10.6.5 Abeona Therapeutics Recent Development
- 10.7 Allergan
- 10.7.1 Allergan Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.7.4 Dermatophytic Onychomycosis Product Introduction
- 10.7.5 Allergan Recent Development
- 10.8 Elorac
- 10.8.1 Elorac Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.8.4 Dermatophytic Onychomycosis Product Introduction
- 10.8.5 Elorac Recent Development
- 10.9 GlaxoSmithKline
- 10.9.1 GlaxoSmithKline Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.9.4 Dermatophytic Onychomycosis Product Introduction
- 10.9.5 GlaxoSmithKline Recent Development
- 10.10 Hexima
- 10.10.1 Hexima Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Dermatophytic Onychomycosis
- 10.10.4 Dermatophytic Onychomycosis Product Introduction
- 10.10.5 Hexima Recent Development
- 10.11 Hisamitsu Pharmaceutical
- 10.12 Mayne Pharma
- 10.13 MediQuest Therapeutics
- 10.14 Meiji Seika Pharma
- 10.15 Merz Pharma
- 10.16 Moberg Pharma
- 10.17 NanoBio
- 10.18 NovaBiotics
- 10.19 Nuvo Research
- 10.20 Pfizer
- 10.21 Polichem
- 10.22 Promius Pharma
- 10.23 Sanofi
- 10.24 Seren Pharmaceuticals
- 10.25 Taro Pharmaceutical
- 10.26 Topica Pharmaceuticals
- 10.27 Viamet Pharmaceuticals
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Dermatophytic Onychomycosis Sales Channels
- 11.2.2 Dermatophytic Onychomycosis Distributors
- 11.3 Dermatophytic Onychomycosis Customers
12 Market Forecast
- 12.1 Global Dermatophytic Onychomycosis Sales and Revenue Forecast 2019-2025
- 12.2 Global Dermatophytic Onychomycosis Sales Forecast by Type
- 12.3 Global Dermatophytic Onychomycosis Sales Forecast by Application
- 12.4 Dermatophytic Onychomycosis Forecast by Regions
- 12.4.1 Global Dermatophytic Onychomycosis Sales Forecast by Regions 2019-2025
- 12.4.2 Global Dermatophytic Onychomycosis Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Dermatophytic Onychomycosis. Industry analysis & Market Report on Dermatophytic Onychomycosis is a syndicated market report, published as Global (United States, European Union and China) Dermatophytic Onychomycosis Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Dermatophytic Onychomycosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
